What is Wegovy and how does it facilitate weight loss?

Wegovy, containing semaglutide, has emerged as a breakthrough in weight management in Dubai, offering a potent solution for individuals grappling with obesity. As with any novel medical treatment, numerous inquiries arise. Here is a comprehensive FAQ tailored for Dubai residents contemplating Wegovy, in alignment with DHA regulations and local considerations.

Wegovy is a prescribed injectable medication comprising semaglutide, a GLP-1 receptor agonist. It operates by mimicking a natural hormone in the body that targets appetite-regulating brain regions.

Mechanism: By curbing hunger, enhancing satiety, and delaying gastric emptying, Wegovy aids in consuming fewer calories and feeling full for longer periods, leading to weight loss when coupled with a reduced-calorie diet and increased physical activity & Wegovy injection in Dubai UAE .

2. Who qualifies for Wegovy in Dubai?

In Dubai, DHA-licensed physicians prescribe Wegovy based on established medical criteria:

Adults (18 years and above):

- BMI of 30 kg/m² or higher (indicative of obesity).

- BMI of 27 kg/m² or higher (indicative of overweight) with at least one weight-related medical condition like hypertension, Type 2 Diabetes, or high cholesterol.

Adolescents (12 years and above):

- BMI at or above the 95th percentile for their age and gender, weighing over 60 kg.

Note: Eligibility hinges on a thorough medical evaluation by a qualified physician to exclude any contraindications.

3. How is Wegovy administered?

Wegovy is dispensed in a pre-filled, single-dose pen and administered via subcutaneous injection once a week.

Injection Sites: The abdomen, thigh, or upper arm are suitable injection sites. Proper injection technique guidance will be provided by your doctor or a nurse at a DHA-sanctioned clinic.

Dose Escalation: Initiated at a low dose (0.25 mg), the dosage is gradually increased over several weeks (typically every four weeks) until reaching a maintenance dose (usually 1.7 mg or 2.4 mg) to allow the body to adapt and minimize side effects.

4. What are the common side effects of Wegovy and their management in Dubai?

Most side effects are mild to moderate and transient, often occurring during dose escalation. Common side effects include:

- Nausea, vomiting, diarrhea, constipation are prevalent.

Solutions: Opt for smaller, frequent meals; select bland, low-fat foods; stay well-hydrated; avoid lying down immediately after eating; and incorporate fiber for constipation. Anti-nausea medication may be prescribed by your Dubai healthcare provider if necessary.

For more, visit: https://www.dha.gov.ae/

5. Are there any serious side effects to be aware of?

Though rare, serious side effects may manifest. Seek immediate medical attention if you encounter:

- Severe abdominal pain indicating pancreatitis or gallbladder issues.

- Signs of severe allergic reactions like facial/throat swelling, breathing difficulties, or severe rash.

- Hypoglycemia symptoms, particularly if diabetic and on other medications.

6. What is the cost of Wegovy in Dubai, and is it covered by insurance?

Pricing: A month's supply of Wegovy typically ranges from AED 1,800 to AED 2,500 in Dubai, contingent on the dosage and the clinic/pharmacy.

Insurance Coverage: Standard health insurance plans in Dubai generally do not cover Wegovy for weight loss, making it an out-of-pocket expense. Some premium or employer plans might offer partial coverage, necessitating direct verification with the insurance provider. Clinics often provide bundled packages combining medication costs with consultations and support services.

Stay tuned for the next part of the revised article!